The stock has a 36-month beta value of 0.59.
The public float for SHPH is 3.34M, and at present, short sellers hold a 21.28% of that float. On May 09, 2025, the average trading volume of SHPH was 752.56K shares.
SHPH) stock’s latest price update
Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH)’s stock price has plunge by 4.65relation to previous closing price of 0.26. Nevertheless, the company has seen a -3.98% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-08 that GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today that it has nearly achieved 50% enrollment in the initial randomized portion of its Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma, with treatment sites reporting that the drug has been well tolerated and toxicity no greater than 2 on a scale of 1-5. Further, 84% of the enrolled patients have completed all seven cycles. Shuttle has begun analyzing pharmacokinetic/pharmacodynamic samples to compare the relationship between dose and response in terms of the extent and duration of Ropidoxuridine’s action. Our objective is to finalize enrollment later this year with follow up and data read out in 2026.
SHPH’s Market Performance
Shuttle Pharmaceuticals Holdings Inc (SHPH) has seen a -3.98% fall in stock performance for the week, with a -33.64% decline in the past month and a -60.58% plunge in the past quarter. The volatility ratio for the week is 7.85%, and the volatility levels for the past 30 days are at 16.71% for SHPH. The simple moving average for the past 20 days is -6.44% for SHPH’s stock, with a -75.56% simple moving average for the past 200 days.
SHPH Trading at -29.36% from the 50-Day Moving Average
After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.27% of loss for the given period.
Volatility was left at 16.71%, however, over the last 30 days, the volatility rate increased by 7.85%, as shares sank -32.52% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -55.00% lower at present.
During the last 5 trading sessions, SHPH fell by -3.98%, which changed the moving average for the period of 200-days by -92.97% in comparison to the 20-day moving average, which settled at $0.2886. In addition, Shuttle Pharmaceuticals Holdings Inc saw -68.57% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SHPH
The total capital return value is set at -7.91. Equity return is now at value -383.84, with -216.24 for asset returns.
Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at -6.24. The debt to equity ratio resting at 1.65. The interest coverage ratio of the stock is -5.66.
Currently, EBITDA for the company is -7.7 billion with net debt to EBITDA at 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.44.
Conclusion
To sum up, Shuttle Pharmaceuticals Holdings Inc (SHPH) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
